Shipra Gandhi

Also affiliated with Emory University, Cancer Institute (WIA), Emory University Orthopaedics and Spine Hospital, Piedmont Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 27 papers. Top paper: “Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity”.

Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2381

N/A

0.749DataRank · unranked

146 citations

Manu Pandey, Kristopher Attwood, Wenyan Ji, Agnieszka K. Witkiewicz, Erik S. Knudsen +14 more

A review of treatment options in HER2‐low breast cancer and proposed treatment sequencing algorithm

Cancer(2023)10.1002/cncr.34904

N/A

0.449DataRank · unranked

19 citations

Vasanthan Muthusamy Kumarasamy, Ajay Dhakal, Ruth O’Regan, Shipra Gandhi, Arya Mariam Roy

Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007381

N/A

0.442DataRank · unranked

18 citations

Mateusz Opyrchal, Melissa Grimm, Ronald Slomba, Kathleen M. Kokolus, Agnieszka K. Witkiewicz +13 more

Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience

Frontiers in Oncology(2022)10.3389/fonc.2022.1012391

N/A

0.442DataRank · unranked

18 citations

Arya Mariam Roy, Kristopher Attwood, Anthony George, Tracey L. O’Connor, Amy Early +3 more

Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience

Clinical Breast Cancer(2024)10.1016/j.clbc.2024.08.005

N/A

0.442DataRank · unranked

18 citations

Archit Patel, Arya Mariam Roy, Malak Alharbi, Ankita Kapoor, Song Yao +13 more

Paclitaxel, interferons and functional reprogramming of tumor-associated macrophages in optimized chemo-immunotherapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010960

N/A

0.396DataRank · unranked

13 citations

Kathleen M. Kokolus, Shipra Gandhi, Paweł Kaliński

Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae128

N/A

0.360DataRank · unranked

10 citations

Haiyang Sheng, Emily C. Liang, Shipra Gandhi, Marilyn L. Kwan, Isaac J. Ergas +8 more

The clinical relevance of unfolded protein response signaling in breast cancer

Research Square(2022)10.21203/rs.3.rs-1480002/v1

N/A

0.345DataRank · unranked

9 citations

Arya Mariam Roy, Shipra Gandhi, Yoshihisa Tokumaru, Li Yan, Akimitsu Yamada +3 more

Infiltration of Common Myeloid Progenitor (CMP) Cells is Associated With Less Aggressive Tumor Biology, Lower Risk of Brain Metastasis, Better Response to Immunotherapy, and Higher Patient Survival in Breast Cancer

Annals of Surgery(2024)10.1097/sla.0000000000006428

N/A

0.292DataRank · unranked

6 citations

Rongrong Wu, Thaer Khoury, Shipra Gandhi, Yan Li, Akimitsu Yamada +4 more

Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gap

Frontiers in Immunology(2024)10.3389/fimmu.2024.1428118

N/A

0.292DataRank · unranked

6 citations

Arya Mariam Roy, Jayasree Krishnan, Paweł Kaliński, Song Yao, Shipra Gandhi +1 more

Establishment of a novel BRCAness score that predicts response to PARP inhibitors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.549

N/A

0DataRank · unranked

0 citations

Shipra Gandhi, Rongrong Wu, Mariko Asaoka, Li Yan, Akimitsu Yamada +6 more

Impact of Concomitant Medication Use and Immune-Related Adverse Events on Response to Immune Checkpoint Inhibitors

Immunotherapy(2020)10.2217/imt-2019-0064

N/A

0DataRank · unranked

33 citations

Manu Pandey, Nischala Ammannagari, Chong Wang, Mark J. Bucsek, Lamya Hamad +3 more

Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies

Seminars in Immunopathology(2020)10.1007/s00281-020-00815-y

N/A

0DataRank · unranked

84 citations

Elizabeth A. Gage‐Bouchard, Christine B. Ambrosone, Elizabeth A. Repasky, Shipra Gandhi, Rohit Gosain

Data from Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

(2023)10.1158/1078-0432.c.6530279

N/A

0DataRank · unranked

0 citations

Manu Pandey, Kristopher Attwood, Wenyan Ji, Agnieszka K. Witkiewicz, Erik S. Knudsen +14 more

490 DiRECT Cohort: An NCORP longitudinal observational trial for disparities in results of immune checkpoint inhibitor treatment between Black and White cancer patients

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0490

N/A

0DataRank · unranked

0 citations

Christine B. Ambrosone, Lori C. Sakoda, Igor PuzanovCI, Eva Culakova, Michelle C. Janelsins +13 more

Systemic chemokine-modulatory regimen combined with neoadjuvant chemotherapy in patients with triple-negative breast cancer

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-010058

N/A

0DataRank · unranked

8 citations

Ronald Slomba, Cayla Janes, Victoria Fitzpatrick, Janine Miller, Kristopher Attwood +19 more

Social networks, social determinants, and mortality: Western New York Exposures and Breast Cancer study

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae057

N/A

0DataRank · unranked

0 citations

Jing Nie, Maurizio Trevisan, Kristopher Attwood, Jo L. Freudenheim, Shipra Gandhi

Dendritic Cell Plasticity, Radiation, and Newton's Third Law

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1506

N/A

0DataRank · unranked

0 citations

Shipra Gandhi, Kathleen M. Kokolus, Paweł Kaliński

Clinicopathological evaluation of triple-negative breast cancer treated with keynote-522 regimen

The Oncologist(2025)10.1093/oncolo/oyaf231

N/A

0DataRank · unranked

1 citations

Shipra Gandhi, Gary Tozbikian, Oluwole Fadare, Samira Syed, Briana To +6 more

Immune and Metabolic Reprogramming Induced by Paclitaxel, Capecitabine and Eribulin in Breast Cancer: Insights into Therapeutic Targets

Breast Cancer Targets and Therapy(2025)10.2147/bctt.s498070

N/A

0DataRank · unranked

0 citations

Riya Patel, Paweł Kaliński, Kazuaki Takabe, Marc S. Ernstoff, Spencer R. Rosario +2 more

Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment

Cancers(2021)10.3390/cancers13112559

N/A

0DataRank · unranked

37 citations

Masanori Oshi, Vijayashree Murthy, Elizabeth A. Repasky, Kazuaki Takabe, Shipra Gandhi

NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation

Cancers(2022)10.3390/cancers14122962

N/A

0DataRank · unranked

39 citations

Arya Mariam Roy, Yoshihisa Tokumaru, Shipra Gandhi, Mariko Asaoka, Masanori Oshi +4 more

Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06633-0

N/A

0DataRank · unranked

77 citations

Shipra Gandhi, Li Yan, Yoshihisa Tokumaru, Rongrong Wu, Akimitsu Yamada +4 more

Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?

Cancers(2022)10.3390/cancers14081856

N/A

0DataRank · unranked

29 citations

Arya Mariam Roy, Ashish Gupta, Kazuaki Takabe, Ajay Dhakal, Mateusz Opyrchal +3 more

Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis

npj Breast Cancer(2022)10.1038/s41523-022-00498-8

N/A

0DataRank · unranked

23 citations

Stuthi Perimbeti, Lei Deng, Charles L. Shapiro, Shipra Gandhi, Changchuan Jiang

Immune Checkpoint Inhibitor–Induced Sicca Syndrome: Early Recognition Is Key

Annals of Internal Medicine Clinical Cases(2025)10.7326/aimcc.2024.1256

N/A

0DataRank · unranked

0 citations

Susan Karki, Audrey Rawleigh, Paweł Kaliński, Alicia Lieberman, Shipra Gandhi +1 more

UACA locus is associated with breast cancer chemoresistance and survival

npj Breast Cancer(2022)10.1038/s41523-022-00401-5

N/A

0DataRank · unranked

15 citations

Emily Schultz, Jirong Long, Janise M. Roh, Emily Valice, Cecile A. Laurent +14 more